WATSON 669 Pill — WHITE ROUND, 8mm — Enalapril

No photo available

Imprint	WATSON / 669
Colour	WHITE
Shape	ROUND
Size	8
Strength	—
Dosage form	Tablet
Manufacturer	Watson Laboratories, Inc.
NDC	0591-0669
Schedule	—
Availability	—
Ingredients	—

What does this imprint mean?

The imprint "WATSON 669" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Enalapril

Uses and warnings

BOXED WARNING: Fetal Toxicity - "When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus." Key warnings: "Angioedema of the face, extremities, lips, tongue, glottis and/or larynx has been reported," which may be fatal with laryngeal involvement; risk of excessive hypotension, especially with volume depletion, heart failure, or diuretic use; may cause "oliguria and/or progressive azotemia and rarely...acute renal failure"; available data are "insufficient to show that enalapril maleate does not" cause agranulocytosis. Contraindicated in patients hypersensitive to the product or with a "history of angioedema related to previous treatment with an angiotensin converting enzyme inhibitor."

Enalapril maleate is indicated for: - "Treatment of hypertension," alone or combined with other antihypertensive agents, particularly thiazide diuretics - "Treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis" - Asymptomatic left ventricular dysfunction (ejection fraction ≤35%), where it "decreases the rate of development of overt heart failure."

Read the full drug profile →